Deccan Hematolink 3.0 convenes top blood cancer experts

Metro India News | Hyderabad: “Deccan Hematolink 3.0,” international conference on AI in oncology and hemato-oncology, brought together over 700 national and 10 international experts on February 21–22, 2026. Dr. G. S. Rao, Managing Director of Yashoda Group Hospitals, emphasized that combating blood cancer requires medical care, mental strength, financial support, and community awareness.

Senior Hematologist Dr. Ganesh Jaishetwar highlighted advances in treatment, noting that innovations like CAR-T therapy and bone marrow transplants have expanded options and improved survival rates. The conference showcased the latest research, diagnostic tools, and patient-care strategies for blood cancers, reflecting rapid global advancements in hematologic care.